Covaxin “Effectively Neutralises” UK Covid Strain, Claims Bharat Biotech


Vaccine maker Bharat Biotech said today that its coronavirus vaccine Covaxin has been found effective against the UK variant of the virus, which is considered 70 per cent more infectious than the Wuhan variety and is more lethal. In a tweet today, Bharat Biotech said “Covaxin effectively neutralises UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape”.

In the tweet, the firm also enclosed a link to the findings of it is research, which was conducted by scientists of the National Institute of Virology.

A vaccine developed by US company Pfizer Inc and its German partner BioNTech is also likely to protect against the more infectious variant, a study posted on online archive said last week.

Covaxin, which is still in trial stage, was approved for use by the country’s drugs regulatory authority earlier this month. The regulator, however, said the vaccine’s use will be in the clinical trial mode, meaning all its recipients will be tracked and monitored as if they are in trial.  

In Delhi, the vaccine is being administered in the six centrally run hospitals. So far, more than 2 million people have been vaccinated across the country.

The UK variant of the virus, which Covaxin was tested against, could be more deadly, British doctors have found.

Share and Enjoy !

0 0